logo
episode-header-image
May 2021
23m 55s

CEO Series: 23andMe’s Anne Wojcicki on S...

Harvard Business Review
About this episode
Anne Wojcicki, CEO of 23andMe, spent a decade in healthcare and biotechnology before launching the DNA testing and analysis company in 2006. Her goal was twofold: to help individuals learn more about their own genetics, enabling them to pursue more personalized medical care, and to create a database of genetic information for commercial and academic research ... Show More
Up next
Jan 2020
How to Capture All the Advantages of Open Innovation
23m 57s
Jan 2020
Revisiting “Jobs To Be Done” with Clayton Christensen
25m 46s
Aug 11
The Innovation Strategy Most Companies Miss
Companies often build products for wealthy markets first and then try to adapt them for the rest of the world. But according to Dartmouth Tuck professor Vijay Govindarajan and MIT professor Amos Winter, designing for the toughest constraints first—whether that's affordability, po ... Show More
31m 13s
Recommended Episodes
Jan 2022
20VC: 23andMe's Anne Wojcicki on How To Approach Trust in Business and Personal Relationships, Leadership Lessons from Sheryl Sandberg and Reflections on How The Best Founders Manage Their Boards
tail spinning
41m 13s
Jun 2025
23andMe's Fatal Flaw | Great Expectorations | 1
When Silicon Valley power-player Anne Wojcicki sees gold in genetics, she forms 23andMe. She wants to bring genetic testing to the masses. But behind the hype and celebrity endorsements, can she build a company that’s selling more than just an expensive novelty product? Be the fi ... Show More
36m 42s
Mar 2021
a16z Bio + Health #7: The Power of Patient Data with Anne Wojcicki
On this episode of the a16z Bio Clubhouse Show, a16z general partners Vineeta Agarwala, Jorge Conde, Julie Yoo, and Vijay Pande, along with a16z cofounder Marc Andreessen, talk to guest Anne Wojcicki, CEO of 23andme. The conversation covers the shifting trends and perceptions at ... Show More
37 m
Aug 2021
372: Biotech Billionaire Anne Wojcicki, Cofounder and CEO of 23andMe
You’ve heard data has the power to make or break a business. Nobody knows this more than Anne Wojcicki, co-founder of biotech giant 23andMe. After 15 years of leveraging data to build a game-changing company, Wojcicki made headlines this summer when she became the latest self-mad ... Show More
53m 20s
Jun 2025
23andMe's Fatal Flaw | Defying Gravity? | 2
Plagued by low sales of its genetic tests, 23andMe adopts a bold new plan: slash prices and enter the pharmaceutical industry. But with investors nervous, can CEO Anne Wojcicki keep the show going long enough to make her DNA dream pay off?Be the first to know about Wondery’s newe ... Show More
39m 17s
Aug 2024
How 23andMe went from a $6 billion valuation to trading for pennies
Cofounder and CEO of 23andMe, Anne Wojcicki, wants to take the public company private. Founded in 2006, the DNA-testing startup was valued at $6 billion in 2021. Now, it’s trading for less than a dollar. So what happened? ‘Fast Company’ senior writer Ainsley Harris breaks down 23 ... Show More
54m 45s
Jun 2025
23andMe's Fatal Flaw | Guess Who’s Back | 3
Just when it looked like 23andMe was selling to Regeneron Pharmaceuticals, founder Anne Wojcicki placed a bid through her new nonprofit in an attempt to win it back at the eleventh hour. Lila MacLellan, Senior Writer at Fortune, joins David to discuss Wojcicki’s leadership style, ... Show More
37m 55s
Oct 2024
Challenging the Status Quo of Healthcare Investment with Annie Lamont
Barry Ritholtz speaks with Annie Lamont, Co-Founder and Managing Partner of Oak HC/FT. Prior to founding Oak HC/FT in 2014, Annie spent 28 years at Oak Investment Partners, where she served as a Managing Partner and led the healthcare and fintech practices. Annie has been named t ... Show More
1h 4m
Listen to millions of songs and podcasts on Anghami